| scholarly article | Q13442814 |
| P356 | DOI | 10.1212/WNL.0B013E318221ACEE |
| P698 | PubMed publication ID | 21593437 |
| P50 | author | Hae-Kwan Cheong | Q38639056 |
| P2093 | author name string | S H Kim | |
| J H Lee | |||
| J S Kim | |||
| H K Park | |||
| S J Oh | |||
| G H Kim | |||
| D L Na | |||
| S W Seo | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dementia | Q83030 |
| Pittsburgh compound B | Q4047010 | ||
| vascular dementia | Q583908 | ||
| P304 | page(s) | 18-25 | |
| P577 | publication date | 2011-05-18 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | Identification of pure subcortical vascular dementia using 11C-Pittsburgh compound B. | |
| P478 | volume | 77 |
| Q92584483 | 18F-THK5351 PET Imaging in Nonfluent-Agrammatic Variant Primary Progressive Aphasia |
| Q27499311 | 18F-florbetaben Aβ imaging in mild cognitive impairment |
| Q35627605 | A Network Flow-based Analysis of Cognitive Reserve in Normal Ageing and Alzheimer's Disease |
| Q47426670 | A mouse model of subcortical vascular dementia reflecting degeneration of cerebral white matter and microcirculation. |
| Q31033082 | Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of Dementia |
| Q27009411 | Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease |
| Q35840614 | Amyloid imaging in the differential diagnosis of dementia: review and potential clinical applications |
| Q38029515 | Antihypertensives for combating dementia? A perspective on candidate molecular mechanisms and population-based prevention |
| Q57214180 | Assessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using 18F-AV1451 Positron Emission Tomography Imaging |
| Q99417370 | Association between APOE ε2 and Aβ burden in patients with Alzheimer- and Vascular-Type Cognitive Impairment |
| Q33767858 | Association between total-Tau and brain atrophy one year after first-ever stroke |
| Q33850834 | Associations between cerebral amyloid and changes in cognitive function and falls risk in subcortical ischemic vascular cognitive impairment |
| Q28533723 | Associations between white matter hyperintensities and β amyloid on integrity of projection, association, and limbic fiber tracts measured with diffusion tensor MRI |
| Q50778486 | Blood-brain barrier P-glycoprotein function in Alzheimer's disease. |
| Q38903262 | Canadian Consensus Guidelines on Use of Amyloid Imaging in Canada: Update and Future Directions from the Specialized Task Force on Amyloid imaging in Canada |
| Q46067045 | Centiloid method evaluation for amyloid PET of subcortical vascular dementia |
| Q35742820 | Cerebrovascular disease, β-amyloid, and cognition in aging |
| Q92673430 | Clinical Usefulness of 18F-FC119S Positron-Emission Tomography as an Auxiliary Diagnostic Method for Dementia: An Open-Label, Single-Dose, Evaluator-Blind Clinical Trial |
| Q35125123 | Clinical and imaging features of mixed Alzheimer and vascular pathologies |
| Q35850730 | Clinical effect of white matter network disruption related to amyloid and small vessel disease |
| Q35590086 | Closing the gap between research techniques and clinical practice in the treatment of dementia |
| Q34973802 | Cluster-based statistics for brain connectivity in correlation with behavioral measures |
| Q38393822 | Cognitive Profile and its Association with Neuroimaging Markers of Non-Demented Cerebral Amyloid Angiopathy Patients in a Stroke Unit |
| Q41533826 | Correlations between Gray Matter and White Matter Degeneration in Pure Alzheimer's Disease, Pure Subcortical Vascular Dementia, and Mixed Dementia. |
| Q50351346 | Cortical thickness and hippocampal shape in pure vascular mild cognitive impairment and dementia of subcortical type. |
| Q38025224 | Dementia in patients hospitalized with stroke: rates, time course, and clinico-pathologic factors |
| Q34071095 | Diagnostic criteria for vascular cognitive disorders: a VASCOG statement |
| Q42683882 | Diagonal Earlobe Crease is a Visible Sign for Cerebral Small Vessel Disease and Amyloid-β. |
| Q52662625 | Disrupted topological organization of resting-state functional brain network in subcortical vascular mild cognitive impairment. |
| Q58577535 | Distinct amyloid distribution patterns in amyloid positive subcortical vascular cognitive impairment |
| Q49012669 | Distinctive Resting State Network Disruptions Among Alzheimer's Disease, Subcortical Vascular Dementia, and Mixed Dementia Patients |
| Q38035398 | EFNS task force: the use of neuroimaging in the diagnosis of dementia. |
| Q36300061 | Effects of amyloid and vascular markers on cognitive decline in subcortical vascular dementia |
| Q47815137 | Effects of cerebrovascular disease and amyloid beta burden on cognition in subjects with subcortical vascular cognitive impairment |
| Q35803904 | Exploring the effects of coexisting amyloid in subcortical vascular cognitive impairment |
| Q36254312 | Hippocampal complex atrophy in poststroke and mild cognitive impairment |
| Q36579657 | Hippocampal subfield volumetry in patients with subcortical vascular mild cognitive impairment |
| Q94461745 | Identifying a subtype of Alzheimer's disease characterised by predominant right focal cortical atrophy |
| Q55617753 | Identifying preclinical vascular dementia in symptomatic small vessel disease using MRI. |
| Q28650395 | Imago Mundi, Imago AD, Imago ADNI |
| Q64247431 | Impact of Pre-Analytical Differences on Biomarkers in the ADNI and PPMI Studies: Implications in the Era of Classifying Disease Based on Biomarkers |
| Q38794960 | Impact of multiple pathologies on the threshold for clinically overt dementia |
| Q47831657 | Impaired memory is more closely associated with brain beta-amyloid than leukoaraiosis in hypertensive patients with cognitive symptoms. |
| Q28534320 | Individual subject classification of mixed dementia from pure subcortical vascular dementia based on subcortical shape analysis |
| Q55104521 | Longitudinal outcomes of amyloid positive versus negative amnestic mild cognitive impairments: a three-year longitudinal study. |
| Q48248949 | MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden. |
| Q57141541 | Magnetic Resonance Imaging and Neuropsychological Correlates of Subcortical Vascular Dementia |
| Q61443427 | Multimodal imaging analyses in patients with genetic and sporadic forms of small vessel disease |
| Q50966742 | Neurobehavioral dysfunction in patients with subcortical vascular mild cognitive impairment and subcortical vascular dementia. |
| Q38297016 | Pathogenesis and treatment of vascular cognitive impairment |
| Q53449003 | Pathogenesis of cerebral microbleeds: In vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment. |
| Q36754568 | Pathology and pathogenesis of vascular cognitive impairment-a critical update |
| Q39277051 | Predicting Regional Pattern of Longitudinal β-Amyloid Accumulation by Baseline PET. |
| Q37653889 | Recent updates on subcortical ischemic vascular dementia |
| Q45996545 | Relative impact of amyloid-β, lacunes, and downstream imaging markers on cognitive trajectories. |
| Q46454611 | Synergistic effects of ischemia and β-amyloid burden on cognitive decline in patients with subcortical vascular mild cognitive impairment |
| Q59806029 | The Brain Donation Program in South Korea |
| Q36165011 | The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations |
| Q46368284 | The Role of Cerebrovascular Disease in Amyloid Deposition. |
| Q37166455 | The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction |
| Q59128736 | The impact of education on cortical thickness in amyloid-negative subcortical vascular dementia: cognitive reserve hypothesis |
| Q41128526 | Toll-like Receptor 2: A Novel Therapeutic Target for Ischemic White Matter Injury and Oligodendrocyte Death. |
| Q46456805 | Tract-Specific Correlates of Neuropsychological Deficits in Patients with Subcortical Vascular Cognitive Impairment. |
| Q51369644 | Vascular Dementia. |
| Q51769067 | Vascular cognitive impairment. |
| Q46523461 | White matter hyperintensities are associated with amyloid burden in APOE4 non-carriers. |
| Q48368417 | White matter microstructural changes in pure Alzheimer's disease and subcortical vascular dementia |
Search more.